Disclosures for "Detection of Neuron-derived cfDNA in Blood Plasma: A Novel Screening and Monitoring Approach for Alzheimer’s Disease and other Neurodegenerative Conditions"
-
Mr. Pollard has received personal compensation for serving as an employee of Renew Biotechnologies. Mr. Pollard has stock in Renew Biotechnologies. Mr. Pollard has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Saito has received personal compensation for serving as an employee of Renew Biotechnologies.
-
Dr. Hill has received personal compensation for serving as an employee of Wasatch Biolabs. Dr. Hill has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Renew Biotechnology. Dr. Hill has stock in Wasatch Biolabs. Dr. Hill has stock in Pioneer Biolabs. Dr. Hill has received research support from NIH. Dr. Hill has received research support from Utah State Alzheimer's Fund. Dr. Hill has received research support from Society for Developmental Biology. Dr. Hill has received research support from Fulbright Commission. Dr. Hill has received research support from Renew Biotechnologies. Dr. Hill has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Renew Research. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Norris, Keplinger, Hicks and Welder. The institution of Dr. Burns has received research support from National Institutes of Health. The institution of Dr. Burns has received research support from Biogen. The institution of Dr. Burns has received research support from Eli Lilly. The institution of Dr. Burns has received research support from Amylyx. The institution of Dr. Burns has received research support from Abbvie. The institution of Dr. Burns has received research support from Astra-Zeneca.
-
Dr. Jenkins has received personal compensation for serving as an employee of Renew Biotechnologies. Dr. Jenkins has stock in Renew Biotechnologies. The institution of Dr. Jenkins has received research support from Renew Biotechnologies. The institution of Dr. Jenkins has received research support from NIH. Dr. Jenkins has received intellectual property interests from a discovery or technology relating to health care.